Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples

Medical Mycology

Volumn 52, Issue 6, 2014, Pages 577-583

  Danylo, Alexis ^a   Courtemanche, Chantal ^b   Pelletier, René ^b   Boudreault, Alexandre A ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

commercial Aspergillus PCR; galactomannan; invasive aspergillosis diagnosis; MycAssay

Indexed keywords

FUNGAL DNA; GALACTOMANNAN; MANNAN;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD SAMPLING; CANCER PATIENT; CARBOHYDRATE ANALYSIS; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DELAYED DIAGNOSIS; DEVICE COMPARISON; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; ELISA KIT; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INTERMETHOD COMPARISON; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; AGED; ASPERGILLUS; COMPARATIVE STUDY; COMPLICATION; ENZYME IMMUNOASSAY; EVALUATION STUDY; GENETICS; HEMATOLOGIC DISEASE; IMMUNOLOGY; INVASIVE PULMONARY ASPERGILLOSIS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; SERUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASPERGILLUS; DNA, FUNGAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 84905035843     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myu025     Document Type: Article

References (25)

1. Parody R, Martino R, Sanchez F et al. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes. Am J Hematol 2009; 84: 571-578.
2. Dimopoulos G, Frantzeskaki F, Poulakou G, Armaganidis A. Invasive aspergillosis in the intensive care unit. Ann N Y Acad Sci 2012; 1272: 31-39.
3. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803; quiz 804-785.
4. Barnes RA, White PL, Bygrave C et al. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. J Clin Path 2009; 62: 64-69.
5. D'Haese J, Theunissen K, Vermeulen E et al. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity. J Clin Microbiol 2012; 50: 1258-1263.
6. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417-1427.
7. Schuetz AN. Invasive fungal infections: biomarkers and molecular approaches to diagnosis. Clin Lab Med 2013; 33: 505-525.
8. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 89-96.
9. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
10. White PL, Bretagne S, Klingspor L et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol 2010; 48: 1231-1240.
11. Schwarzinger M, Sagaon-Teyssier L, Cabaret O et al. Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model. PLoS One 2013; 8: e65776.
12. Kawazu M, Kanda Y, Nannya Y et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42: 2733-2741.
13. Springer J, Morton CO, Perry M et al. Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients. J Clin Microbiol 2013; 51: 1445-1450.
14. Torelli R, Sanguinetti M, Moody A et al. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J Clin Microbiol 2011; 49: 4273-4278.
15. Guinea J, Padilla C, Escribano P et al. Evaluation of MycAssay Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer. PLoS One 2013; 8: e61545.
16. Orsi CF, Gennari W, Venturelli C et al. Performance of 2 commercial real-time polymerase chain reaction assays for the detection of Aspergillus and Pneumocystis DNA in bronchoalveolar lavage fluid samples from critical care patients. Diagn Microbiol Infect Dis 2012; 73: 138-143.
17. White PL, Perry MD, Moody A et al. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis. J Clin Microbiol 2011; 49: 2169-2174.
18. Baskova L, Buchta V. Laboratory diagnostics of invasive fungal infections: an overview with emphasis on molecular approach. Folia Microbiol (Praha) 2012; 57: 421-430.
19. Lass-Florl C, Gunsilius E, Gastl G et al. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol 2004; 42: 4154-4157.
20. Kami M, Fukui T, Ogawa S et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001; 33: 1504-1512.
21. McCulloch E, Ramage G, Rajendran R et al. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis. J Clin Path 2012; 65: 83-86.
22. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762-1769.
23. Hummel M, Spiess B, Cornely OA et al. Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial. Eur J Haematol 2010; 85: 164-169.
24. Marchetti O, Lamoth F, Mikulska M et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47: 846-854.
25. Bellete B, Flori P, Hafid J, Raberin H, Tran Manh Sung R. Influence of the quantity of nonspecific DNA and repeated freezing and thawing of samples on the quantification of DNA by the Light Cycler. J Microbiol Methods 2003; 55: 213-219.